Page 87 - 78_04

MIND
LINES
AGAINST
GUIDELINES
IN
TREATMENT
OF
MALARIA
…

(n=
321),
artemether
17.4
%
(n=
104),
sulphadoxine/pyremethamine
10.5%
(n=

63)
and
amidaquine
HCl
7.7
%
(n=
46)
(Table
3).

Table
2.-­-
Demographics.

Parameter F (%)

Designation 48 (8)
Specialists 346 (57.8)
Medical officer 206 (34.3)
House office
121 (20.2)
Experience 244 (40.7)
Less than one year 142 (23.7)
1-5 years 93 (15.5)
6-10 years
More than 10 years 90 (15)
510 (85)
Prescribers aware of malaria STGs
Yes
No

Prescribers received any training on malaria STGs 60 (10)
540 (90)
Yes
No

Availability of STG for malaria in health facilities 10 (1.7)
Yes 590 (98.3)
No

Prescriptions
n = 600
Table
3.-­-
Prescribing
trends
in
tertiary
healthcare
facilities.
F (%)

Indicator 226 (37.7 %)
55 (9.2 %)
Diagnosis written on prescriptions 175 (29.2 %)
Results of MP test on prescriptions 126 (21 %)
Antibiotics prescribed 554 (92.4 %)
Injections prescribed 18 (3 %)
Anti-pyretic prescribed 66 (11 %)
Prescribing by generic name 321 (53.5 %)
Chloroquine phosphate prescribed 104 (17.3 %)
Artemether/lumefentraine prescribed 63 (10.5 %)
Artemether prescribed 46 (7.7 %)
Sulphadoxine/pyremethamine prescribed
Amodiaquine HCl prescribed

505